SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011686
Filing Date
2024-08-09
Accepted
2024-08-09 10:15:38
Documents
52
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q viri-20240630x10q.htm   iXBRL 10-Q 791146
2 EX-31.1 viri-20240630xex31d1.htm EX-31.1 12317
3 EX-31.2 viri-20240630xex31d2.htm EX-31.2 12208
4 EX-32.1 viri-20240630xex32d1.htm EX-32.1 6886
5 EX-32.2 viri-20240630xex32d2.htm EX-32.2 6902
  Complete submission text file 0001558370-24-011686.txt   3538914

Data Files

Seq Description Document Type Size
6 EX-101.SCH viri-20240630.xsd EX-101.SCH 29402
7 EX-101.CAL viri-20240630_cal.xml EX-101.CAL 24880
8 EX-101.DEF viri-20240630_def.xml EX-101.DEF 102474
9 EX-101.LAB viri-20240630_lab.xml EX-101.LAB 260029
10 EX-101.PRE viri-20240630_pre.xml EX-101.PRE 192224
55 EXTRACTED XBRL INSTANCE DOCUMENT viri-20240630x10q_htm.xml XML 408641
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39811 | Film No.: 241190748
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)